Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)

CNY 28.93

(-3.21%)

Total Liabilities Summary of Nanjing Well Pharmaceutical Group Co.,Ltd.

  • Nanjing Well Pharmaceutical Group Co.,Ltd.'s latest annual total liabilities in 2023 was 686.22 Million CNY , up 4.65% from previous year.
  • Nanjing Well Pharmaceutical Group Co.,Ltd.'s latest quarterly total liabilities in 2024 Q3 was 603.6 Million CNY , down -13.9% from previous quarter.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported annual total liabilities of 655.75 Million CNY in 2022, up 43.8% from previous year.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported annual total liabilities of 456.01 Million CNY in 2021, up 35.41% from previous year.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported quarterly total liabilities of 660.59 Million CNY for 2024 Q1, down -3.73% from previous quarter.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported quarterly total liabilities of 701.02 Million CNY for 2024 Q2, up 6.12% from previous quarter.

Annual Total Liabilities Chart of Nanjing Well Pharmaceutical Group Co.,Ltd. (2023 - 2014)

Historical Annual Total Liabilities of Nanjing Well Pharmaceutical Group Co.,Ltd. (2023 - 2014)

Year Total Liabilities Total Liabilities Growth
2023 686.22 Million CNY 4.65%
2022 655.75 Million CNY 43.8%
2021 456.01 Million CNY 35.41%
2020 336.75 Million CNY 55.15%
2019 217.05 Million CNY 12.12%
2018 193.58 Million CNY 0.45%
2017 192.72 Million CNY 23.35%
2016 156.24 Million CNY -19.05%
2015 193.01 Million CNY 7.86%
2014 178.94 Million CNY 0.0%

Peer Total Liabilities Comparison of Nanjing Well Pharmaceutical Group Co.,Ltd.

Name Total Liabilities Total Liabilities Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 4.7 Billion CNY 85.408%
Yabao Pharmaceutical Group Co., Ltd 860.33 Million CNY 20.237%
Shandong Lukang Pharmaceutical Co.,Ltd. 4.95 Billion CNY 86.137%
Zhejiang Huahai Pharmaceutical Co., Ltd. 10.34 Billion CNY 93.369%
Chongqing Taiji Industry(Group) Co.,Ltd 10.52 Billion CNY 93.481%
Tasly Pharmaceutical Group Co., Ltd 3.86 Billion CNY 82.246%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 3.49 Billion CNY 80.35%
Lionco Pharmaceutical Group Co.,Ltd. 693.51 Million CNY 1.052%
Joincare Pharmaceutical Group Industry Co.,Ltd. 13.34 Billion CNY 94.859%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 440.92 Million CNY -55.633%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.6 Billion CNY 57.219%
China Animal Husbandry Industry Co., Ltd. 2.38 Billion CNY 71.209%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 1.6 Billion CNY 57.343%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 2.2 Billion CNY 68.946%
Zhejiang Shengda Bio-Pharm Co., Ltd. 449.19 Million CNY -52.767%
Harbin Pharmaceutical Group Co., Ltd. 8.37 Billion CNY 91.802%
Zhejiang Medicine Co., Ltd. 2.79 Billion CNY 75.432%
HPGC Renmintongtai Pharmaceutical Corporation 4.55 Billion CNY 84.932%
Humanwell Healthcare (Group) Co.,Ltd. 15.38 Billion CNY 95.54%
Ginwa Enterprise (Group) Inc. 470.12 Million CNY -45.966%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 2.24 Billion CNY 69.422%
KPC Pharmaceuticals, Inc. 3.9 Billion CNY 82.428%
Henan Lingrui Pharmaceutical Co., Ltd. 1.97 Billion CNY 65.223%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 299.24 Million CNY -129.314%
Ningbo Menovo Pharmaceutical Co., Ltd. 2.23 Billion CNY 69.335%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.47 Billion CNY 53.403%
Zhongzhu Healthcare Holding Co.,Ltd 422.34 Million CNY -62.48%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 40.9 Billion CNY 98.323%
China National Medicines Corporation Ltd. 14.87 Billion CNY 95.386%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.54 Billion CNY 55.443%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 515.97 Million CNY -32.996%
Jianmin Pharmaceutical Group Co.,Ltd. 1.89 Billion CNY 63.747%
Beijing Tongrentang Co., Ltd 9.67 Billion CNY 92.907%
North China Pharmaceutical Company Ltd. 14.68 Billion CNY 95.327%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 3.52 Billion CNY 80.539%
CanSino Biologics Inc. 3.86 Billion CNY 82.247%
Zhejiang Hisun Pharmaceutical Co., Ltd. 9.26 Billion CNY 92.592%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 4.42 Billion CNY 84.493%
ChengDu ShengNuo Biotec Co.,Ltd. 431.06 Million CNY -59.19%
Dali Pharmaceuticalco.,Ltd 92.7 Million CNY -640.19%
Tibet Weixinkang Medicine Co., Ltd. 436.54 Million CNY -57.193%
Changchun BCHT Biotechnology Co. 1.01 Billion CNY 32.46%
Shanghai Jiaoda Onlly Co.,Ltd 475.91 Million CNY -44.19%
Jiang Zhong Pharmaceutical Co.,Ltd 1.6 Billion CNY 57.231%
Mayinglong Pharmaceutical Group Co., LTD. 959.61 Million CNY 28.49%
Cisen Pharmaceutical Co., Ltd. 1.57 Billion CNY 56.33%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 696.15 Million CNY 1.427%
Hunan Warrant Pharmaceutical Co.,Ltd 358.76 Million CNY -91.273%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 56.77 Billion CNY 98.791%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.49 Billion CNY 54.015%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.38 Billion CNY 79.752%
Guobang Pharma Ltd. 2.92 Billion CNY 76.535%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 1.03 Billion CNY 33.493%
Shandong Buchang Pharmaceuticals Co., Ltd. 9.2 Billion CNY 92.544%
Zhejiang Starry Pharmaceutical Co.,Ltd. 3.66 Billion CNY 81.293%
Kangmei Pharmaceutical Co., Ltd. 7.19 Billion CNY 90.469%
Henan Taloph Pharmaceutical Stock Co.,Ltd 1.95 Billion CNY 64.813%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.65 Billion CNY 58.414%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.64 Billion CNY 81.195%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 805.75 Million CNY 14.835%
Shanghai Shyndec Pharmaceutical Co., Ltd. 4.89 Billion CNY 85.97%
Shanghai Yizhong Pharmaceutical Co., Ltd. 107.05 Million CNY -541.01%
Tibet Rhodiola Pharmaceutical Holding Co. 1.18 Billion CNY 42.231%
Sichuan Huiyu Pharmaceutical Co., Ltd. 886.91 Million CNY 22.628%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 1.33 Billion CNY 48.728%